Jelly Roll explains avoiding GLP-1 drugs in weight loss

Country star Jelly Roll has dropped nearly 300 pounds over two years without using popular GLP-1 medications like Ozempic. The 41-year-old singer opened up in Men's Health about tackling his food addiction through therapy instead. From low testosterone woes to reignited romance, he's spilling all the transformative tea.

Oh honey, Jelly Roll is serving realness in his latest Men's Health chat, and we're here for every unfiltered bite. The Grammy-nominated crooner, who's been on a wellness whirlwind for two years, started at a hefty 540 pounds and is now cruising at 265—talk about shedding the past! But why skip the GLP-1 hype like Ozempic or Mounjaro? "I just remember everyone telling me GLP-1s... ‘Listen, it’s gonna hurt your stomach a little bit,’" he told Men's Health. "I’ve treated my body so bad, I can’t believe God’s gave me this voice for this long. I didn’t deserve it. I literally didn’t do it out of fear." 🔥

Instead of quick fixes, Jelly Roll went deep, treating his overeating like the addiction it was—much like his battles with cocaine and codeine. "Even before I got into getting my blood work done, I went and got mental health therapy about my overeating," he shared. "I started treating my food addiction like what it was: an addiction... Once I started treating food like an addiction, it started changing everything for me." Therapy first, then the pounds melted away the hard way.

The perks? He's feeling youthful AF. "I feel like I’m a teenager, dog," he joked. "I have the sex drive of a 17-year-old again. I’m f–king pouncing on my wife. We’re having daytime sex again. It’s f–king awesome." But pre-loss, things were rough: his testosterone was a measly 57—preteen levels! "[Before the weight loss] my testosterone level... was of a preteen boy... dude, we’re talking a 57... The first couple of blood panels were like, ‘How are you alive?’" Oof, married to a 'smoke show' and still struggling? Relatable mess.

Now, he's all in on this lifestyle, chasing a 'feeling weight' over numbers. He feels it everywhere—from dribbling on the basketball court to snuggling with wife Bunnie Xo without tumbling off the bed. (Side note: Bunnie shared their tough IVF updates this summer—sending love. 💕) But excess skin? That's the dramatic downside. "There’s so much skin under here. I’m starting to meet with skin surgeons to talk about possibly cutting skin in the next year," he admitted. "It’s a symbol of a war that I fought with myself. But equally, it is in the f–king way... [I’ll] probably have to clip these titties off eventually." Proud scars or not, he's owning it.

Jelly Roll's journey screams resilience—will the skin snip be his next big glow-up? Spill your thoughts, darlings.

Related Articles

Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Image generated by AI

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Reported by AI Image generated by AI Fact checked

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Teddi Mellencamp, the Real Housewives of Beverly Hills alum, spilled on her podcast that she begged her doctor for GLP-1 weight-loss drugs while battling cancer. She gained weight from steroids but got shut down. Joking about the irony, she quipped about living her best life without the meds.

Reported by AI

Young Indians are turning to diabetes drugs Ozempic and Mounjaro for rapid weight loss before weddings and job interviews, as experts warn of cosmetic misuse, grey market dangers, and rising lookism. These GLP-1 drugs are meant for obesity and diabetes, not vanity purposes, doctors emphasize.

Researchers at Vanderbilt Health discovered that both popular weight loss drugs and bariatric surgery significantly reduce fat mass while causing modest losses in fat-free mass, including muscle, in patients with obesity. The findings, based on over 3,000 patients, show improvements in overall body composition over 24 months. Maintaining this balance is crucial for long-term health, the study emphasizes.

Reported by AI

A new analysis of clinical trials indicates that semaglutide, the active ingredient in Ozempic and Wegovy, helps older adults with obesity lose substantial weight and improve heart health markers. The findings come from data on participants aged 65 and above who received the once-weekly medication alongside lifestyle changes.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline